Suelen S Mello1,2, Daria Van Tyne3,4, Francois Lebreton3,4, Simone Q Silva5,6, Mara C L Nogueira5, Michael S Gilmore3,4, Ilana L B C Camargo2. 1. Federal University of São Carlos, São Carlos, Brazil. 2. São Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil. 3. Harvard Medical School, Boston, MA, USA. 4. Massachusetts Eye and Ear Infirmary, Boston, MA, USA. 5. Departamento de Doenças Dermatológicas, Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto - FAMERP, São José do Rio Preto, Brazil. 6. Instituto de Biociências, Letras e Ciências Exatas (IBILCE) - UNESP, São José do Rio Preto, Brazil.
Abstract
OBJECTIVES: To verify dissemination of daptomycin-non-susceptible Enterococcus faecium in a hospital where daptomycin was not in use and to understand the evolutionary pathways connecting daptomycin hypersusceptibility to non-susceptibility. METHODS: Clonality of 26 E. faecium was assessed by PFGE and the STs of these isolates were determined. The most daptomycin-susceptible isolate was evolved in vitro by stepwise daptomycin selection, generating isolates for genome comparisons. RESULTS: The spread of a high-risk daptomycin-non-susceptible VRE clone was detected, as was the occurrence of an unusual daptomycin-hypersusceptible strain (HBSJRP18). To determine the basis for daptomycin hypersusceptibility, we evolved HBSJRP18 in vitro and identified candidate genetic alterations potentially related to daptomycin susceptibility. Both lafB, encoding glycosyltransferase, which is putatively involved in lipoteichoic acid (LTA) biosynthesis, and dak, encoding a dihydroxyacetone kinase likely involved in fatty acid metabolism, were mutated in multiple independent experiments. Trans-complementation showed that the lafB polymorphism naturally occurring in HBSJRP18 caused its daptomycin hypersusceptibility. Fourier-transform infrared spectroscopy identified differences between the extracted LTA spectra from the hypersusceptible isolate and its revertant, as well as other non-susceptible variants, supporting a role for LafB in E. faecium LTA biosynthesis. Zeta potential difference was detected in one evolved dak mutant derivative. While much more susceptible to daptomycin, HBSJRP18 showed enhanced growth in the presence of piperacillin, suggesting that this, or another cell wall-targeting antibiotic, may have selected for the daptomycin-hypersusceptible phenotype. CONCLUSIONS: Our findings provide new information on the basis for daptomycin susceptibility in E. faecium, with implications for limiting the development and spread of daptomycin resistance.
OBJECTIVES: To verify dissemination of daptomycin-non-susceptible Enterococcus faecium in a hospital where daptomycin was not in use and to understand the evolutionary pathways connecting daptomycin hypersusceptibility to non-susceptibility. METHODS: Clonality of 26 E. faecium was assessed by PFGE and the STs of these isolates were determined. The most daptomycin-susceptible isolate was evolved in vitro by stepwise daptomycin selection, generating isolates for genome comparisons. RESULTS: The spread of a high-risk daptomycin-non-susceptible VRE clone was detected, as was the occurrence of an unusual daptomycin-hypersusceptible strain (HBSJRP18). To determine the basis for daptomycin hypersusceptibility, we evolved HBSJRP18 in vitro and identified candidate genetic alterations potentially related to daptomycin susceptibility. Both lafB, encoding glycosyltransferase, which is putatively involved in lipoteichoic acid (LTA) biosynthesis, and dak, encoding a dihydroxyacetone kinase likely involved in fatty acid metabolism, were mutated in multiple independent experiments. Trans-complementation showed that the lafB polymorphism naturally occurring in HBSJRP18 caused its daptomycin hypersusceptibility. Fourier-transform infrared spectroscopy identified differences between the extracted LTA spectra from the hypersusceptible isolate and its revertant, as well as other non-susceptible variants, supporting a role for LafB in E. faecium LTA biosynthesis. Zeta potential difference was detected in one evolved dak mutant derivative. While much more susceptible to daptomycin, HBSJRP18 showed enhanced growth in the presence of piperacillin, suggesting that this, or another cell wall-targeting antibiotic, may have selected for the daptomycin-hypersusceptible phenotype. CONCLUSIONS: Our findings provide new information on the basis for daptomycin susceptibility in E. faecium, with implications for limiting the development and spread of daptomycin resistance.
Authors: Ashley D Hall Snyder; Brian J Werth; Poochit Nonejuie; John P McRoberts; Joe Pogliano; George Sakoulas; Juwon Yim; Nivedita Singh; Michael J Rybak Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191
Authors: Anna-Barbara Hachmann; Elif Sevim; Ahmed Gaballa; David L Popham; Haike Antelmann; John D Helmann Journal: Antimicrob Agents Chemother Date: 2011-06-27 Impact factor: 5.191
Authors: François Lebreton; Willem van Schaik; Abigail Manson McGuire; Paul Godfrey; Allison Griggs; Varun Mazumdar; Jukka Corander; Lu Cheng; Sakina Saif; Sarah Young; Qiandong Zeng; Jennifer Wortman; Bruce Birren; Rob J L Willems; Ashlee M Earl; Michael S Gilmore Journal: mBio Date: 2013-08-20 Impact factor: 7.867
Authors: Gregory S Canfield; Anushila Chatterjee; Juliel Espinosa; Mihnea R Mangalea; Emma K Sheriff; Micah Keidan; Sara W McBride; Bruce D McCollister; Howard C Hang; Breck A Duerkop Journal: Antimicrob Agents Chemother Date: 2021-03-01 Impact factor: 5.191
Authors: Michael S Gilmore; Rauf Salamzade; Elizabeth Selleck; Noelle Bryan; Suelen S Mello; Abigail L Manson; Ashlee M Earl Journal: mBio Date: 2020-11-24 Impact factor: 7.867
Authors: Gayatri Shankar Chilambi; Hayley R Nordstrom; Daniel R Evans; Jose A Ferrolino; Randall T Hayden; Gabriela M Marón; Anh N Vo; Michael S Gilmore; Joshua Wolf; Jason W Rosch; Daria Van Tyne Journal: Proc Natl Acad Sci U S A Date: 2020-05-11 Impact factor: 11.205